Matching slides 13,863
Current window 10,021-10,050
Pages 463
Rows per page 30
Component: Legendclear collectionreset all

Component

10,021-10,050 of 13,863

filter-aware
33
The chart highlights a clear trend of improving profitability, specifically showing Adj. EBITDA moving toward zero.Grove | Investor Presentation Deck | 41 slides · Grove Collaborative
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
23
The chart includes a trend arrow indicating CAGR for both deposit types.Hanmi Financial | Results Presentation Deck | 47 slides · Hanmi Financial
Conference presentation Investor relations 1 hit
08
The slide categorizes markets by population size (MSAs > 1M vs < 1M) and displays HTLF's rank and deposit volume in each.Heartland Financial USA | Results Presentation Deck | 53 slides · HTLF
Conference presentation Investor relations Beat · Rising SuccessLoop · Before After1 hit
17
The slide uses stacked bar charts to visualize the composition of assets and liabilities over two time periods.Hexagon Purus | Results Presentation Deck | 38 slides · Hexagon Purus
Conference presentation Investor relations Beat · Financials1 hit
24
The slide uses a dual-track timeline format to distinguish between strategic and commercial milestones.Hexagon Purus | Results Presentation Deck | 38 slides · Hexagon Purus
Conference presentation Investor relations Beat · Closing Ask1 hit
27
The chart displays revenue in millions, broken down by Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.Houlihan Lokey | Investor Presentation Deck | 33 slides · Houlihan Lokey
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
08
The chart uses a line for sales and bars for EBIT margin, with a projection for 2023-2025.Hugo Boss | Investor Day Presentation Deck | 107 slides · Hugo Boss
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
09
The chart highlights Hugo Boss in a distinct color (gold) compared to the grey bars of competitors.Hugo Boss | Investor Day Presentation Deck | 107 slides · Hugo Boss
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
Includes a waterfall-style bridge annotation explaining the gross margin decrease.Hydrafacial | Results Presentation Deck | 42 slides · BeautyHealth
Conference presentation Investor relations 1 hit
12
The slide uses a hub-and-spoke diagram to connect the product (center) to clinical use cases (right) and development drivers (left).Hyperfine | Investor Presentation Deck | 16 slides · Hyperfine
Pitch deck Investor relations 1 hit
18
The chart demonstrates deepening clinical responses over time, a key indicator of therapeutic efficacy in oncology trials.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
19
The slide uses a red dashed box to highlight the key efficacy metrics for comparison.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
46
The slide uses a bar chart comparison to highlight the efficacy gap between established treatments and placebo, likely to frame the market opportunity for IMX-120.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
22
The chart demonstrates deepening clinical responses over time for NXC-201 therapy.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
24
The slide highlights specific safety data points for a competitor product to establish a benchmark.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
49
The slide compares efficacy of Humira, Stelara, and Entyvio against placebo in clinical trials.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
24
The chart demonstrates deepening clinical responses over time, with sCR/CR increasing from 50% to 83%.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
52
The slide uses a bar chart comparison to highlight the efficacy gap between established treatments and placebo.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
11
The slide uses stacked bar charts to show revenue composition across four segments: Data/Patient Network, Women's health, Rare diseases/Other, and Oncology.Invitae | Results Presentation Deck | 28 slides · Invitae
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · Zoom In1 hit
15
Includes footnotes regarding non-GAAP measures and revenue/patient calculation exclusions.Invitae | Results Presentation Deck | 28 slides · Invitae
Conference presentation Investor relations Beat · Key Performance Indicators Overview1 hit
16
Includes footnotes regarding pro forma revenue and cash burn definitions.Invitae | Results Presentation Deck | 28 slides · Invitae
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
07
The slide uses a Gantt-chart style layout to show the progression of various drug programs.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
18
The slide compares cytokine inhibition across three cohorts (MAD3 Healthy Subjects, Part C AD Patients, Part C HS Patients) using two different stimuli (LPS and R848).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Desire1 hit
22
The chart tracks patient outcomes over time, showing a shift from severe/moderate to mild categories.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · DesireLoop · Aha Moment1 hit
25
Data presented for All HS Patients (N=12) and Moderate to Severe (N=10) subgroups.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Desire1 hit
07
The chart uses a combination of bar (Net Sales) and line (Margins) to visualize the impact of the pandemic on financial performance.Lakeland Bancorp | Investor Conference Presentation Deck | 19 slides · Lakeland
Conference presentation Investor relations Beat · KPI OverviewLoop · Cost Of Inaction1 hit
14
Lanvin | Results Presentation Deck | 36 slidesLanvin | Results Presentation Deck | 36 slides · Lanvin Group
Conference presentation Investor relations Beat · Satisfaction1 hit
09
The slide uses color-coded bars to indicate geographic focus (Global, US, China) for each clinical program.Legend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Key Performance Indicators Overview1 hit
13
The map uses color coding to distinguish between current branch locations/tuck-in opportunities and potential new target geographies.Limbach Holdings | Investor Presentation Deck | 26 slides · Limbach
Pitch deck Investor relations 1 hit
15
Includes FCF conversion metrics and full-year outlook markers for 2023.LKQ | Results Presentation Deck | 61 slides · LKQ
Conference presentation Investor relations Loop · Benchmark Gap1 hit